|
Sino Biological
slimp 2 fc Slimp 2 Fc, supplied by Sino Biological, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/limp2/Human+LIMP-2+%2F+SCARB2+%2F+CD36L2+Protein/pm38666485-380-2-3 Average 92 stars, based on 1 article reviews
slimp 2 fc - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
limp2 scarb2 Limp2 Scarb2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/limp2/LIMP-2%2FSCARB2+Rabbit+mAb/pmc10975504-54-0-2 Average 92 stars, based on 1 article reviews
limp2 scarb2 - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
OriGene
human scarb2 gene ![]() Human Scarb2 Gene, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/limp2/LIMPII+(SCARB2)+(NM_005506)+Human+Untagged+Clone/pmc04163470-41-4-10 Average 90 stars, based on 1 article reviews
human scarb2 gene - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Proteintech
limp2 ![]() Limp2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/limp2/LIMPII+Antibody/bio_rxiv__2025__09__04__674289-200-120-130 Average 93 stars, based on 1 article reviews
limp2 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
ABclonal Biotechnology
anti scarb2 a9185 poly antibody ![]() Anti Scarb2 A9185 Poly Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/limp2/SCARB2+Rabbit+pAb/pmc10120312-90-1-11 Average 90 stars, based on 1 article reviews
anti scarb2 a9185 poly antibody - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
MedChemExpress
human cd3 cd28 t cell activator magnetic beads ![]() Human Cd3 Cd28 T Cell Activator Magnetic Beads, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/limp2/SCARB2%2FLIMP-2%2C+Human/pmc12982294-111-8-38 Average 93 stars, based on 1 article reviews
human cd3 cd28 t cell activator magnetic beads - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
ProSci Incorporated
limp2 ![]() Limp2, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/limp2/LIMP2+Antibody/pmc04788783__mmc2-293-16-18 Average 90 stars, based on 1 article reviews
limp2 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Sino Biological
human scarb2 cdna ![]() Human Scarb2 Cdna, supplied by Sino Biological, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/limp2/Human+LIMP-2+SCARB2+Gene+ORF+cDNA+clone+expression+plasmid/pmc04932649__emi201656x4-33-19-30 Average 92 stars, based on 1 article reviews
human scarb2 cdna - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
Absolute Biotech Inc
anti-limp-2 ectodomain antibody ![]() Anti Limp 2 Ectodomain Antibody, supplied by Absolute Biotech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/limp2/rabbit+anti+mouse+limp+2/pmc05712522-353-10-13 Average 90 stars, based on 1 article reviews
anti-limp-2 ectodomain antibody - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: BioMed Research International
Article Title: Delivery of Human EV71 Receptors by Adeno-Associated Virus Increases EV71 Infection-Induced Local Inflammation in Adult Mice
doi: 10.1155/2014/878139
Figure Lengend Snippet: Expression of recombinant AAV-hSCARB2 and AAV-hPSGL1 in cell lines increased susceptibility to EV71 infection. (a) Green fluorescence protein (GFP), human PSGL1 (hPSGL1), and human SCARB2 (hSCARB2) were cloned into the pEMBL plasmid with a CB promoter (pEMBL-CB). (b) L929 cells were transfected with pEMBL-CB-hPSGL1 and the expression of hPSGL1 was detected by surface stained with anti-hPSGL1 antibody and FITC-conjugate anti-mouse IgG and then analyzed by flow cytometry. (c) L929 cells were transfected with pEMBL-CB-hSCARB2 and the expression of hSCARB2 was detected by surface stained with anti-human SCARB2 and FITC-conjugate anti-mouse IgG and then analyzed by flow cytometry. (d) L929 cells transfected with the vector pEMBL-CB (Mock), pEMBL-CB-hSCARB2 (hSCARB2), and pEMBL-CB-hPSGL1 (hPSGL1) were infected with live EV71 (MOI = 1.0). Forty-eight hours after infection, protein extracted from cells was analyzed by Western blot using anti-EV71 VP1 and anti-actin antibodies. (e) Identical L929 cell treatment as described in (d) was observed for the cytopathic effect (CPE) by microscopy. Cells with CPE are labeled with a black arrow.
Article Snippet: Plasmid pCMV-hSCARB2 containing the
Techniques: Expressing, Recombinant, Infection, Fluorescence, Clone Assay, Plasmid Preparation, Transfection, Staining, Flow Cytometry, Western Blot, Microscopy, Labeling
44 ] The domains and motifs are colored as follows: pink: antiparallel beta‐sheet (domain 1); grey: TIM barrel (domain 2) containing active site (green); blue: beta‐barrel (domain 3); [ Journal: Advanced Science
Article Title: Activation and Purification of ß ‐Glucocerebrosidase by Exploiting its Transporter LIMP‐2 – Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease
doi: 10.1002/advs.202401641
Figure Lengend Snippet: Interaction of GCase variants with their lysosomal transporter LIMP‐2. A) Crystal structure of GCase (PDB: 5LVX). [
Article Snippet: For expression of
Techniques: Binding Assay, Labeling, Activity Assay, Transfection, Western Blot, Expressing, Control, Over Expression, Variant Assay, Comparison
Journal: Advanced Science
Article Title: Activation and Purification of ß ‐Glucocerebrosidase by Exploiting its Transporter LIMP‐2 – Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease
doi: 10.1002/advs.202401641
Figure Lengend Snippet: Characterization of primary human fibroblasts of controls and patients with PD and GD. A) Western blot of whole cell lysates from control (CTRL‐1,2,3), PD patient‐derived (PD‐1,2), and GD patient‐derived (GD) primary human fibroblasts. Quantitative analysis of signals can be found in Figure (Supporting Information). GCase levels were comparable between control and PD but diminished in GD (Figure , Supporting Information). LIMP‐2 levels were increased in PD compared to controls (Figure , Supporting Information). LAMP‐2A and calnexin levels varied between cell lines and did not show any significant trend between groups (Figure , Supporting Information). GAPDH and CBB staining of the gel are presented as loading controls. B) GCase activity in whole‐cell lysates of control, PD, and GD fibroblast cell lines (n = 3‐7; CTRL‐1,2,3: 7; PD‐1,2: 7; GD: 3; individual cell harvests). The E326K lines PD‐1 and PD‐2 showed significantly lower GCase activity (66.41±2.69% and 73.56±6.50%) compared to the control lines. In contrast, activity in the GD line (GBA1 L444P/L444P ) was almost fully abolished (3.11±0.11% residual activity). C) Colocalization of LIMP‐2 and GCase in primary human fibroblasts determined via Pearson's correlation coefficient (n = CTRL‐1: 30; CTRL‐2: 38; CTRL‐3: 33; PD‐1: 44; PD‐2: 51; GD: 27; individual cells from multiple images). PD patient fibroblasts PD‐1 and PD‐2 show mildly reduced colocalization of LIMP‐2 and GCase compared to control lines. In the GD patient line, colocalization was diminished even further. D) Representative immunofluorescence images of primary human fibroblast lines. Objective magnification: 40x. Green: LIMP‐2; red: GCase, blue: DAPI. All lines show the vesicular distribution of LIMP‐2, indicating lysosomes. Control and PD lines show visible colocalization of GCase with the LIMP‐2 signal. In GD fibroblasts, the GCase signal was less intense and less granular, representing lower expression and lysosomal localization. Statistics: replicates (dots) with mean (column) ± SEM (B); violin plot with median (dashed line) and quartiles (dotted line) (C). Tests: Nested one‐way ANOVA with Tukey's multiple comparison test (B,C). * p < 0.05; ** p < 0.01; **** p < 0.0001.
Article Snippet: For expression of
Techniques: Western Blot, Control, Derivative Assay, Staining, Activity Assay, Immunofluorescence, Expressing, Comparison
Journal: Advanced Science
Article Title: Activation and Purification of ß ‐Glucocerebrosidase by Exploiting its Transporter LIMP‐2 – Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease
doi: 10.1002/advs.202401641
Figure Lengend Snippet: Purification of GCase utilizing soluble (s) LIMP‐2. A) Workflow for the purification of sLIMP‐2/GCase complex from HEK 293F cells. A culture is transfected to co‐express sLIMP‐2 and GCase. After 96 h, the conditioned medium is collected and Ni‐NTA purification of His‐tagged proteins is performed, yielding sLIMP‐2 and sLIMP‐2/GCase complex. Elution fractions are concentrated and separated via SEC, yielding purified sLIMP‐2/GCase protein complex. B) Cartoon of intracellular mechanisms of interaction and secretion of GCase with the soluble sLIMP‐2 construct. A soluble sLIMP‐2/GCase complex is formed in the ER. The IgK leader sequence on sLIMP‐2 then facilitates secretion of the LIMP‐2/GCase complex instead of sorting GCase to the lysosome. In comparison, the sLIMP‐2‐3xD control construct does not bind GCase and therefore does not facilitate secretion of GCase. C) GCase activity in the supernatant of HEK 293F cells overexpressing wt GCase along either sLIMP‐2 or sLIMP‐2‐3xD (n = 3; individual transfections). Samples were taken 0‐72 h after transfection. In co‐expression with sLIMP‐2, GCase activity is higher and stable over the course of the measurements, whereas activity in the control is lower and diminishes over time. The statistical significance indicated (*) represents a comparison between both sample groups at a given time point. D) Representative western blot of analytical samples from Ni‐NTA purification of the sLIMP‐2/GCase complex from HEK 293F supernatant. Parts of the blot are shown with increased contrast to visualize faint signals. Splicing is indicated by a dashed line. Abbreviations: cond. SN: conditioned supernatant; dep. SN: depleted supernatant; wash 1/4: flow‐through of washing steps 1/4 (4 total); elution F1: elution fraction 1 (5 total). Elution of protein from Ni‐NTA resin yielded sLIMP‐2 and GCase. E) Representative SEC profiles of samples from Ni‐NTA purification of sLIMP‐2/GCase (blue), sLIMP‐2 (black), and His‐tagged GCase (grey, dashed) using a Superdex 200 Increase 3.2/300 column. sLIMP‐2 and sLIMP‐2/GCase samples share a peak at fraction 8 corresponding to the sLIMP‐2 monomer. An additional peak in fraction 7 is visible in the sLIMP‐2/GCase sample, corresponding to the sLIMP‐2/GCase complex. His‐tagged GCase runs as a major peak in fractions 4/5 with training smaller peaks in later fractions. F) Western Blot analyses of SEC fractions (corresponding to Figure ). Fractions of the sLIMP‐2/GCase sample show strong GCase and LIMP‐2 signals with maxima at fractions 7/8 and 8/9 respectively. Fractions of sLIMP‐2 show the same distribution with a weak GCase signal. His‐tagged GCase was most abundant in fractions 5/6. Statistics: replicates (dots, squares) with mean (line) ± SEM (C). Tests: Two‐way ANOVA with Sidak's multiple comparison test (C). ** p < 0.01, *** p < 0.001, **** p < 0.0001 .
Article Snippet: For expression of
Techniques: Purification, Transfection, Construct, Sequencing, Comparison, Control, Activity Assay, Expressing, Western Blot
Journal: Advanced Science
Article Title: Activation and Purification of ß ‐Glucocerebrosidase by Exploiting its Transporter LIMP‐2 – Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease
doi: 10.1002/advs.202401641
Figure Lengend Snippet: Design and effect of LIMP‐2‐derived helix 5 peptide on GCase function. A) Sequence of custom LIMP‐2 peptides. The peptides comprise the wt or 3xD variant of helix 5 of LIMP‐2 (orange), flanked by an N‐terminal lysosomal KFERQ sequence for lysosomal targeting (green) and a C‐terminal TAT‐peptide for cell penetration (pink). Linker regions are indicated in grey. B) Cartoon of uptake of LIMP‐2‐derived peptide into cells and the lysosome, where the peptide interacts with GCase, boosting its lysosomal function. C,D) Interaction of L2H5‐wt and GCase‐His at cytosolic (C) and lysosomal (D) pH as determined by MST (n = 3 sample preparations per condition). Dots represent mean ± SEM. With increasing concentration of ligand (L2H5‐wt), changes in the MST signal (FNorm) could be observed at both conditions, indicating binding to GCase. Fitting of a Kd model (red line) yielded estimated affinities in the nanomolar range for pH 7.4 and micromolar range for pH 5.0. At pH 7.4, higher L2H5 concentrations lead to a second change in the MST signal, hinting toward a second binding event with lower affinity (illustrated as a grey dashed line). Grey datapoints were disregarded for the Kd model fit (red line). E) Enzyme activity of Cerezyme in the presence of varying concentrations of L2H5‐wt or −3xD peptides (n = 3; individual experiments). An activating effect of L2H5‐wt was first observed in the micromolar range and increased further with peptide concentration. The addition of 10 µM of L2H5 led to a 2.63 ± 0.22‐fold increase of GCase activity. At peptide concentrations above 20 µM, precipitation of the peptide occurred as indicated by a dashed grey line. F) Effect of L2H5 peptides on the activity of recombinant GCase in conditioned HEK 293F media after overexpression of GCase variants (n = 3, individual experiments). The activity of wt GCase and E326K were increased in the presence of 10 µM L2H5‐wt. The activity of N370S and L444P were unaffected. Statistics: mean (dot) ± SEM (C,D), replicates (dots, squares) with mean (line) ± SEM (E); Mean (column) ± SEM (F). Tests: non‐linear regression Kd model (C,D); two‐way ANOVA with Tukey's multiple comparison test (F). * p < 0.05, **** p < 0.0001, n.s.: not significant .
Article Snippet: For expression of
Techniques: Derivative Assay, Sequencing, Variant Assay, Concentration Assay, Binding Assay, Activity Assay, Recombinant, Over Expression, Comparison
Journal: Advanced Science
Article Title: Activation and Purification of ß ‐Glucocerebrosidase by Exploiting its Transporter LIMP‐2 – Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease
doi: 10.1002/advs.202401641
Figure Lengend Snippet: Uptake and effect of L2H5 peptides on control and PD fibroblasts. A) Assessment of cell death via LDH activity in culture medium in CTRL‐2, PD‐1, and PD‐2 fibroblast lines (n = 3; wells from the 96‐well plate). Cells were treated with varying concentrations of L2H5‐wt peptide for 72 h. concentrations up to 10 µM did not lead to an increase in cell death. At a concentration of 20 µM however, LDH activity in the medium was significantly increased, indicating increased cell death due to treatment. Effects were comparable between all three lines. Significance is shown in comparison to the 0 µM data group for each cell line respectively. B) Presence of tryptic exogenous L2H5‐wt and endogenous LIMP‐2‐derived peptides in LE fractions of HEK293T cells after treatment with PBS (neg. ctrl.) or 5 µM L2H5‐wt for 2 h and 24 h. Determined via mass spectrometry. The positive control represents a sample spiked with 0.5 µg of L2H5 before analysis. L2H5‐wt‐specific peptides 1‐4 were detected in the pos. ctrl (all 4) and the cells treated with L2H5‐wt for 2 h (peptides 2 and 3). Low amounts of peptides 2 and 3 were also detected at the 24 h time point, but only by matching (indicated with an asterisk) and only in two of the three samples. Peptide 5, which is a tryptic product of both L2H5‐wt and endogenous LIMP‐2, was detected in all samples as expected, with higher abundance in the spiked control and the 2 h treated samples. C) Representative immunofluorescence image of CTRL‐2 fibroblasts with GFP‐labeled lysosomes (CellLight Lysosomes‐GFP) after 2 h of treatment with 0.25 µg µL −1 FRed‐L2H5‐wt. Objective magnification: 63x. Top: single channels. Middle: merged picture. Bottom: zoomed in single channels and merged picture of area inside a white frame. Green: GFP; red: FusionRed; blue: DAPI. FusionRed signal dots were visible within the cell. Some dots were surrounded by GFP signal located in the lysosomal membrane, thus confirming the presence of FRed‐L2H5‐wt inside the lysosome as shown by white arrows and in the zoomed‐in section. D) Live cell GCase activity in primary human control fibroblasts and PD‐patient‐derived fibroblasts harboring E326K mutations (n = 3; wells of a 96‐well plate). The cells were treated with PBS or L2H5 peptides (wt and 3xD). The graph shows lysosomal GCase activity as an area between curves (see materials and methods). In all three cell lines, lysosomal GCase activity was dramatically boosted after treatment with L2H5‐wt. In contrast, treatment with the non‐binding L2H5‐3xD peptide did not affect lysosomal GCase activity. See Figure (Supporting Information) for individual activity graphs with replicates. Statistics: replicates (dots) with mean (column) ± SEM (A); mean (column) ± SEM (D). Tests: Two‐way ANOVA with Dunnett's multiple comparison test (A); Two‐way ANOVA with Tukey's multiple comparison test (D). * p < 0.05, *** p < 0.001 **** p < 0.0001, n.s.: not significant .
Article Snippet: For expression of
Techniques: Control, Activity Assay, Concentration Assay, Comparison, Derivative Assay, Mass Spectrometry, Positive Control, Immunofluorescence, Labeling, Membrane, Binding Assay
Journal: Nature Communications
Article Title: Lysosomal integral membrane protein-2 as a phospholipid receptor revealed by biophysical and cellular studies
doi: 10.1038/s41467-017-02044-8
Figure Lengend Snippet: Structure of lipids bound LIMP-2 dimer. a Lipid-bound LIMP-2 adopts a dimeric structure. The twofold axis of the dimer is perpendicular to the plane of the figure at the center. Protein ribbons are colored green and cyan for different subunits. Endogenous ligands, recognized as phosphatidylcholine (PC) and cholesterol (CLR), are shown in stick model, with carbon atoms colored magenta, oxygen red, nitrogen blue, and phosphorus orange. Carbon atoms in glycan moieties are colored yellow. Image prepared using pymol . The N and C termini and the helical bundles are labeled. b Zoomed-in view of one of the hydrophobic tunnels (calculated using program caver ) in the LIMP-2 dimer; the entrances/exit to the hydrophobic tunnel are indicated by arrows. Bound lipids with their relative orientation to the cell membrane, and the helical bundle of the second subunit are indicated. Exit and entrance 2 are the proximal and distal openings highlighted in Fig. . c PC and CLR molecules in the hydrophobic tunnel are shown embedded in 2mFo-DFc composite omit map (blue mesh) contoured at 1.0 σ . d – f Surface electrostatic potential presentations of the LIMP-2 dimer. Color bar indicates blue positive and red negative charges, with neutral shown in white. Bound ligands in view are shown in yellow spheres for CLR, and cyan for PC, and cleft bound PC is indicated. Surface cationic patches are enclosed in dashed boxes and residues forming these patches are labeled. d The putative distal face of the LIMP-2 dimer. e Side view of the dimer. Orientation of the luminal domain relative to the cell membrane is indicated. f The putative cell membrane proximal face of the LIMP-2 dimer. Notice that CLR molecules are visible through openings on both the distal ( d ) and the proximal ( f ) faces. a and f , and c and e have the same views, respectively. For clarity, glycans are omitted in d – f
Article Snippet: For live cell surface labeling, MEF were incubated with an
Techniques: Labeling
Journal: Nature Communications
Article Title: Lysosomal integral membrane protein-2 as a phospholipid receptor revealed by biophysical and cellular studies
doi: 10.1038/s41467-017-02044-8
Figure Lengend Snippet: Ligand binding sites and dimerization interface of LIMP-2 compared to apo LIMP-2 monomer structure. a Each subunit (cyan ribbons) of the LIMP-2 dimer has extensive conformational changes compared to those of the apo LIMP-2 monomer (gray ribbons, PDB code 4Q4F). The helical bundle of the second subunit (α4, α5, and α7 in green ribbons) is shown to indicate the location of dimer interface. b The PC-binding site at the hydrophobic tunnel. The head group of bound PC displaces the α9 helix from its position in the apo structure, and interacts with K205, D272, and K330 (labeled). Hydrogen bonds are shown as dashes. Residues chosen for dimerization interfering mutations (H150 and F151) are indicated. c Extensive conformational changes observed surrounding the CLR-binding site. Residues V415 and A379, the equivalent residue proposed to be in the cholesterol path in SR-B1, are highlighted. Regions that are affected by CLR binding are labeled. d The hydrophobic tunnel of the apo LIMP-2 (gray mesh) is significantly different in shape and location from that of the LIMP-2 dimer (cyan solid surface) upon CLR and PC binding. e Hydrophobic cleft and the putative bound PC fragment, with contacting residues side chains shown in sticks. Equivalent residues that are important for HDL uptake by SR-BI or fatty acid or oxLDL uptake by CD36 are colored orange on the main chain. f The expansive mannose-6 glycans (M6D), P-Man9GlcNAc2 at N325, contribute to dimer interactions. Hydrogen bonds involving N-glycan are shown in dashes
Article Snippet: For live cell surface labeling, MEF were incubated with an
Techniques: Ligand Binding Assay, Binding Assay, Labeling
Journal: Nature Communications
Article Title: Lysosomal integral membrane protein-2 as a phospholipid receptor revealed by biophysical and cellular studies
doi: 10.1038/s41467-017-02044-8
Figure Lengend Snippet: LIMP-2 binding to liposomes characterized by SPR, NS-EM, and DLS. a Binding kinetics of LIMP-2 to liposomes at pH 7.5 were characterized by SPR. Representative SPR sensorgrams (colored traces) of LIMP-2 monomer (left) and dimer (right) binding to immobilized POPC (top panel), DOPS:DOPC (3:2) (middle) and POPS liposomes (bottom) at concentrations indicated were overlaid with kinetic fitting curves (black) using 1:1 kinetic model. The binding responses are scaled according to dimer-POPS responses. Immobilized levels of POPC, DOPS:DOPC (3:2), and POPS on the L1 SPR chip were 8900, 7500, and 6000 units, respectively. b Examples of negative stain EM micrographs indicate the LIMP-2 dimer bridges POPS liposomes and induces clustering of liposomes. Red arrow indicates a clear example of two liposomes forming a tight association with a clear boundary bridged by LIMP-2 dimer (insert is enlarged view). Blue arrow indicates a grape bundle shaped cluster of multiple liposomes. These features are not observed in any images of BSA and LIMP-2 monomer samples, which were used as negative controls. Total numbers of images observed were 5, 8, 16, and 12 for BSA + POPS, monomer + POPS, POPS, and POPS + LIMP-2 dimer, from duplicated experiments. c Addition of LIMP-2 dimer into POPS liposome (red) shifts the DLS profiles of POPS liposome (black). POPS liposome with BSA (blue) used as a negative control. The average radii are 50.6 ± 0.4, 6.53 ± 0.06, 68.6 ± 1.1, 3.84 ± 0.02, 52.4 ± 4 Å for PS liposome, LIMP-2 dimer, PS + LIMP-2 dimer, BSA, and PS + BSA, respectively from 15 measurements of each duplicated experiments. The estimated molecular weights of POPS and POPS + LIMP-2 dimer are 32,774 ± 1300 and 66,557 ± 2500 KD, respectively
Article Snippet: For live cell surface labeling, MEF were incubated with an
Techniques: Binding Assay, Staining, Negative Control
Journal: Nature Communications
Article Title: Lysosomal integral membrane protein-2 as a phospholipid receptor revealed by biophysical and cellular studies
doi: 10.1038/s41467-017-02044-8
Figure Lengend Snippet: Detection of LIMP-2 dimer in live cells using bimolecular fluorescence complementation method. a Schematic illustration of constructs designed for bimolecular fluorescence complementation in examining dimerization of LIMP-2. b High-resolution confocal images of Hela cells expressing LIMP-2 (WT, top, or H150A/F151D, bottom) fused to the N-terminal and C-terminal fragments of Venus fluorescent protein along with Lamp1-RFP co-transfected as a lysosome colocalization marker. c Western blot showing expression levels of the LIMP-2 WT and H150A/F151D variants using anti-myc and anti-HA antibodies. d Quantification of the ratio of mean Venus fluorescence intensity relative to ER-localized mCherry for cells transfected with LIMP-2 (WT and H150A/F151D) fused to the N-terminal and C-terminal fragments of Venus fluorescent protein fluorescence. Data is expressed as mean ± SEM, ~60 cells each experiment, n = 3, **** P < 0.0001, t test. Scale bar 20 µm
Article Snippet: For live cell surface labeling, MEF were incubated with an
Techniques: Fluorescence, Construct, Expressing, Transfection, Marker, Western Blot
Journal: Nature Communications
Article Title: Lysosomal integral membrane protein-2 as a phospholipid receptor revealed by biophysical and cellular studies
doi: 10.1038/s41467-017-02044-8
Figure Lengend Snippet: LIMP-2 mediates the endocytosis of liposomes in cells. a Immunocytochemistry of LIMP-2 in MDCK monolayer culture. Endogenous LIMP-2 proteins (green, nuclear content blue) were found not only inside the cell but also enriched on the cell surface that formed borders between cells. b , c Time-lapse images of a MDCK cell transfected with a LIMP-2-HA construct (enlarged view in insets; time stamp shown in yellow). LIMP-2-HA located on the cell surface was visualized by surface labeling of mouse anti-HA antibody and anti-mouse Fab fragment conjugated to AlexaFluor488. A LIMP-2 containing endocytic vesicle (arrowhead) formed within 14 s was detected in c but not in b . d Western blotting with anti-LIMP-2 antibody. e – g Surface labeling of LIMP-2 in WT or KO MEF. h Quantification of surface labeling with LIMP-2 or IgG isotype antibody. i – k 30 min uptake of PC or PS liposomes in MEF. i WT MEF with few intracellular PC particles (arrow). j WT MEF with intracellular PS particles (green). k LIMP-2 KO MEF with few intracellular PS particles (arrow). l Quantification of liposome uptake in WT and LIMP-2 KO MEF. m , n Dyngo-2a (100 μM, 15 min) blocks both PS liposome (green) uptake and transferrin (red) endocytosis. o Nystatin (100 μM, 15 min) inhibits the endocytosis of PS liposome (green) but not transferrin (red). p Quantification of PS fluorescence intensity in WT MEF treated with endocytosis inhibitor Dyngo-2a or nystatin. q – t Endocytosed PS vesicles (green) were partially localized to lysosomes (lysotracker, red) after 60 min of uptake. t Enlarged view of the square in s . Results are expressed as means ± SE. *, t test P = 3.8E−4; **, t test P < 2.2E−14. Blue, DAPI. Scale bar: a – k , 12 µm; m – o , 25 µm; q – t , 12 µm
Article Snippet: For live cell surface labeling, MEF were incubated with an
Techniques: Immunocytochemistry, Transfection, Construct, Labeling, Western Blot, Fluorescence
Journal: Nature Communications
Article Title: Lysosomal integral membrane protein-2 as a phospholipid receptor revealed by biophysical and cellular studies
doi: 10.1038/s41467-017-02044-8
Figure Lengend Snippet: Proposed mechanism of lipids trafficking by LIMP-2. Lipids (green spheres) binding of LIMP-2 monomer promote dimer formation. In the LIMP-2 dimer the luminal domains are closer to the cell membrane, with the proximal face of LIMP-2 luminal domain able to interact with the cell membrane while its distal face able to interact with extracellular lipid vesicles, respectively, via their cationic patches. Within the tethers of the protein on the luminal side, between the ends of the structurally defined polypeptides and the transmembrane helices, there are sufficient residues that are flexible and lack defined secondary structure to enable this dimerization on cell surface: 24 residues after the last residue of the N-terminal transmembrane helix and 6 before the beginning of the C-terminal transmembrane helix. If fully extended, these tethers can stretch at least 20 Å. Notice the channels in LIMP-2 ectodomain dimer connect bound lipid vesicles and cell membrane, with openings near cationic patches in both faces that may facilitate lipids exchange between vesicles and outer leaflet of the cell membrane. LIMP-2 bound lipid vesicles can be trafficked into cell cytosol via endocytosis
Article Snippet: For live cell surface labeling, MEF were incubated with an
Techniques: Binding Assay